Daily non-political popular news in brief.

Higher doses of radiation for prostate cancer do not decrease sexual function

Recent advances in the delivery of radiation therapy for prostate cancer are fueling a new trend of providing higher radiation doses over shorter periods of time. But does the daily increase in radiation lead to more sexual dysfunction than the conventional dose? New research by physicians at Fox Chase Cancer Center says it does not.

Read more »

Keywords: higher, doses, radiation, prostate, cancer, decrease, sexual, function, dose

« Previous | Next »

Similar news on "Higher doses of radiation for prostate cancer do not decrease sexual function":

1. Prostate cancer less likely to spread when treated with higher dose of radiation
   11-06-2006 · EurekAlert!
   New research suggests that men with prostate cancer who choose radiation therapy should seek treatment centers that will offer high-dose radiation. A new study from Fox Chase Cancer Center finds that higher doses of radiation greatly reduces the risk that the cancer will spread later -- even eight to 10 years after treatment.
   Similar news · Read more »
   
2. Increasing radiation dose shortens treatment time for women who choose breast sparing treatment
   05-29-2007 · EurekAlert!
   Radiation therapy after lumpectomy for early-stage breast cancer can be safely delivered in higher daily doses to greatly reduce treatment time. This conclusion of a new Fox Chase Cancer Center study is good news for women who might opt to have a mastectomy instead of a lumpectomy because of the time commitment needed for the usual six-week radiation course with the breast-sparing surgical option.
   Similar news · Read more »
   
3. IMRT versus 3D CRT for prostate cancer, new long-term data assesses side effects
   11-05-2006 · EurekAlert!
   New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group. These and other data, including long-term genitourinary side effects, were presented today.
   Similar news · Read more »
   
4. Prostate drug doesn't limit sexual function in most men
   07-19-2007 · EurekAlert!
   Men taking finasteride reported on average a slight decrease in sexual function that diminished during a seven-year study with 17,000 participants. The drug, used to treat enlarged prostate, has been proven effective at preventing prostate cancer.
   Similar news · Read more »
   
5. Can cholesterol-lowering medicine make radiation more effective at curing prostate cancer?
   10-29-2007 · EurekAlert!
   Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session Oct. 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
   Similar news · Read more »
   
6. Prostate cancer patients see high survival rates with seed implants
   01-31-2007 · EurekAlert!
   More than 90 percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis, according to a study released in the February 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of ASTRO.
   Similar news · Read more »
   
7. Ultra-low-dose aspirin might decrease bleeding severity in portal hypertension
   10-09-2007 · EurekAlert!
   A team led by Dr. Christian Doutremepuich from the University of Bordeaux 2 has determined that the paradoxical prothrombotic effects of ultra-low-dose aspirin, that could have beneficial properties decreasing bleeding complications of portal hypertension, are mediated by inhibition of Cyclooxygenase 2. This effect differs to the usual inhibition of Cyclooxygenase 1 at higher doses that has an antithrombotic action.
   Similar news · Read more »
   
8. JCI table of contents: June 7, 2007
   06-07-2007 · EurekAlert!
   This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online June 7, 2007, in the JCI, including: "Combination therapy reduces tumor resistance to radiation"; "Improved prediction of prostate cancer recurrence"; "Role of GM-CSF in the immune response to tumors"; "Protein C signaling impacts inflammatory bowel disease"; "Iron imbalance in anemia: Hints from HIF"; and "Phosphorylation state of eNOS is key to blood vessel function."
   Similar news · Read more »
   
9. Reactions to 'false-positive' prostate cancer screenings assessed
   03-02-2007 · EurekAlert!
   Men who get a "false-positive" prostate cancer result -- an abnormal screening test followed by a biopsy indicating no evidence of cancer -- appear more likely to worry about their subsequent risk of cancer and report more problems with sexual function compared to men with normal screening results.
   Similar news · Read more »
   
10. Integrated approach to radiation therapy provides quality care for cancer patients
    11-07-2006 · EurekAlert!
    Results from a University of Pittsburgh study demonstrate that intensity-modulated radiation therapy (IMRT) can be uniformly delivered in a large health care system of academic and community cancer centers through a centralized planning and treatment process. According to study results, there were no significant differences in toxicity profiles and recommended radiation dose prescriptions in 758 prostate cancer patients treated with IMRT at 12 separate community cancer centers and one academic flagship facility.
    Similar news · Read more »